Antigen Discovery Receives SBIR Grant for Development of Novel Microfludic Diagnostic Device
Biotechnology company, Antigen Discovery has been awarded a Phase I Small Business Innovation and Research (SBIR) grant from the National Institute of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID).
The US $600,000 grant will be disbursed over a period of two years to support the joint research initiative between Antigen and the University of California’s (UCI) Henry Samueli School of Engineering to devise a completely integrated microfluidic point-of-care diagnostic platform.
The risk of contracting infectious diseases has risen with threat from bioterrorism, natural disease outbreaks and mass disasters. This has fostered the need for swift, accurate and instantly deployable diagnostics. The collaborative effort between Antigen and UCI is to develop such a diagnostic device by integrating the innovative air-liquid cavity acoustic transducer (ALCAT) technology established by Dr. Abraham Lee's team at UCI, protein microarray technology from Antigen and a vast collection of serodiagnostic antigens sourced from targeted infectious diseases.
According to Dr. Abraham Lee, most point-of-care (POC) diagnostics employ different actuators for each fluidic process. The ALCAT’s single actuation technology makes it easier to incorporate it on a chip which in turn simplifies the integration of ALCAT-based approach with protein microarray assays. This serves to reduce production costs and development time of enzymes as all components can be integrated in a disposable assay. Though Antigen has been awarded numerous grants by SBIR in the past, this is the first time a grant has been awarded for medical device development.
Written by
Will has a B.Sc. in Chemistry from the University of Durham, and a M.Sc. in Green Chemistry from the University of York. Naturally, Will is our resident Chemistry expert but, a love of science and the internet makes Will the all-rounder of the team. In his spare time Will likes to play the drums, cook and brew cider.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Soutter, Will. (2019, February 12). Antigen Discovery Receives SBIR Grant for Development of Novel Microfludic Diagnostic Device. AZoNano. Retrieved on February 05, 2026 from https://www.azonano.com/news.aspx?newsID=25405.
MLA
Soutter, Will. "Antigen Discovery Receives SBIR Grant for Development of Novel Microfludic Diagnostic Device". AZoNano. 05 February 2026. <https://www.azonano.com/news.aspx?newsID=25405>.
Chicago
Soutter, Will. "Antigen Discovery Receives SBIR Grant for Development of Novel Microfludic Diagnostic Device". AZoNano. https://www.azonano.com/news.aspx?newsID=25405. (accessed February 05, 2026).
Harvard
Soutter, Will. 2019. Antigen Discovery Receives SBIR Grant for Development of Novel Microfludic Diagnostic Device. AZoNano, viewed 05 February 2026, https://www.azonano.com/news.aspx?newsID=25405.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.